SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Spectrum Pharmaceuticals, Inc. Announces Outstanding ZEVALIN® Clinical Data In Aggressive Relapsed/Refractory Lymphoma; Presented at the 17th Congress of the European Hematology Association
Your Message